What the name refers to
A melanocortin receptor agonist authorised as bremelanotide for one defined sexual-desire disorder indication in premenopausal women.
Evidence and regulatory context
At least one regulated medicine or indication exists for this active ingredient. Authorisation is tied to a particular formulation, manufacturer, indication and jurisdiction; it does not validate unrelated products using the same name.
Reading product records
These names do not form one pharmacological class. Each record must be read compound by compound, with special attention to the difference between an authorised medicine, an investigational candidate, a regional product and an online research listing.
Primary research links
Use current regulator and study records rather than treating a catalogue description as medical evidence.